Janet M McNicholl
Overview
Explore the profile of Janet M McNicholl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
81
Citations
2075
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Denson D, Tesfaye C, Glusberg D, Schoua-Glusberg A, Betley V, Gale B, et al.
J Racial Ethn Health Disparities
. 2025 Jan;
PMID: 39760837
Young Black women in the southern US face a high HIV burden. While daily oral HIV pre-exposure prophylaxis (PrEP) can effectively prevent HIV, its use is low among Black women....
2.
Garber D, Guenthner P, Zhao C, Mitchell J, Ellis S, Jia H, et al.
AIDS
. 2023 Jan;
37(5):723-731.
PMID: 36625252
Objective: Sexually transmitted infections (STIs) increase mucosal HIV infection risk and have the potential to reduce preexposure prophylaxis efficacy. Clinical trials of a broadly neutralizing antibody (bNAb) provided proof-of-concept that...
3.
Miller M, Cash-Goldwasser S, Marx G, Schrodt C, Kimball A, Padgett K, et al.
MMWR Morb Mortal Wkly Rep
. 2022 Nov;
71(44):1412-1417.
PMID: 36327164
As of October 21, 2022, a total of 27,884 monkeypox cases (confirmed and probable) have been reported in the United States. Gay, bisexual, and other men who have sex with...
4.
Garcia-Lerma J, McNicholl J, Heneine W
Curr Opin HIV AIDS
. 2022 Jun;
17(4):179-185.
PMID: 35762371
Purpose Of Review: We review macaque models for preexposure prophylaxis (PrEP) for HIV prevention and highlight their role in advancing currently approved and novel PrEP agents. Recent Findings: The development...
5.
Vishwanathan S, Zhao C, Luthra R, Khalil G, Morris M, Dinh C, et al.
AIDS
. 2021 Sep;
36(2):169-176.
PMID: 34482355
Objective: We had previously shown that long-acting cabotegravir (CAB-LA) injections fully protected macaques from vaginal simian HIV (SHIV) infection. Here, we reassessed CAB-LA efficacy in the presence of depot medroxyprogesterone...
6.
Garber D, Guenthner P, Mitchell J, Ellis S, Gazumyan A, Nason M, et al.
AIDS
. 2021 May;
35(10):1567-1574.
PMID: 33966028
Objective: The opioid epidemic has increased parentally acquired HIV infection. To inform the development of a long-acting prevention strategy, we evaluated the protective efficacy of broadly neutralizing antibodies (bNAbs) against...
7.
Gunaydin G, Edfeldt G, Garber D, Asghar M, Nol-Romas L, Burgener A, et al.
Sci Rep
. 2019 Dec;
9(1):18120.
PMID: 31792342
Natural-product derived lectins can function as potent viral inhibitors with minimal toxicity as shown in vitro and in small animal models. We here assessed the effect of rectal application of...
8.
HIV-1 genetic diversity to estimate time of infection and infer adherence to preexposure prophylaxis
Council O, Ruone S, Mock P, Khalil G, Martin A, Curlin M, et al.
AIDS
. 2019 Nov;
33(15):2299-2307.
PMID: 31764095
Objective: To estimate time of HIV infection in participants from the Bangkok Tenofovir Study (BTS) with daily oral tenofovir disoproxil fumarate (TDF) for preexposure prophylaxis (PrEP) and relate infection with...
9.
Martin M, Vanichseni S, Sangkum U, Mock P, Leethochawalit M, Chiamwongpaet S, et al.
EClinicalMedicine
. 2019 May;
9:44-51.
PMID: 31143881
Background: Three consecutive prospective studies were conducted among people who inject drugs (PWID) from May 1995 through June 2012 in Bangkok, Thailand. We examined data from these studies to evaluate...
10.
Martin M, Vanichseni S, Leelawiwat W, Anekvorapong R, Raengsakulrach B, Cherdtrakulkiat T, et al.
WHO South East Asia J Public Health
. 2019 Apr;
8(1):50-55.
PMID: 30950431
Background: Approximately 1% of adults in Thailand are infected with hepatitis C virus (HCV). New direct-acting antiviral agents achieve sustained virologic responses in >95% of HCV-infected patients and are becoming...